Skip to main content

Arsenic in Drinking Water (1999) / Chapter Skim
Currently Skimming:

5 Disposition of Inorganic Arsenic
Pages 150-176

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 150...
... or arsenate As(V) was absorbed from the gastrointestinal tract of humans and experimental animals (Pomroy et al.
From page 151...
... Variations in arsenic methylation in humans are reviewed in more detail in Chapter 7. Arsenate Reduction and Arsenite Methylation In humans and in most experimental animals, inorganic arsenic is methylated to monomethylarsonic acid (MMA)
From page 152...
... . Essentially the same sequence of alternating reduction and methylation reactions was postulated for various mammals exposed to inorganic arsenic (Challenger 1945)
From page 153...
... reported that the methylating capacity of red blood cells, brain, lung, intestine, and kidneys of rats was insignificant compared with that of the liver. In vitro studies using arsenite methyltransferases from mouse tissues showed that the highest amount of methylating activity is in the testes, followed by kidney, liver, and lung (Healy et al.
From page 154...
... Many experimental animals excrete less MMA and more DMA in the urine than do humans. Mice and dogs methylate inorganic arsenic efficiently,
From page 155...
... Arsenite methyltransferase activity, tested by incubation of liver preparations with arsenite in vitro, has been detected in the liver of the rabbit, rat, mouse, hamster, pigeon, and rhesus monkey but not in the liver of the marmoset monkey, tamarin monkey, squirrel monkey, chimpanzee, and guinea pig
From page 156...
... In decreasing order, the species with liver arsenite methyltransferase activity are the pigeon, rhesus monkey, mouse, hamster, rabbit, marmoset monkey, squirrel monkey, and tamarin monkey. In addition, when guinea pigs were injected intraperitoneally with radioactive arsenate, five of six guinea pigs did not have methylated arsenic species in their urine (Healy et al.
From page 157...
... A further discussion of the dose-dependence of arsenic methylation in humans exposed via drinking water is presented in Chapter 8. Results from in vitro studies suggested that the delay in urinary excretion of DMA might occur because of the high tissue concentrations of arsenite inhibit the methyltransferase catalyzing the second methylation step (Buchet and Lauwerys 1985)
From page 158...
... In vitro studies on arsenic methylation in rat-liver cytosol showed that chelating agents, such as DMSA and DMPS (0.05-0.5 mM) , almost completely inhibit the methylation of inorganic arsenic to DMA (Buchet and Lauwerys 1985, 1988)
From page 159...
... . Arsenic concentrations were found to be significantly higher in the serum and erythrocytes of chronic hemodialysis patients compared with controls (De Kimpe et al.
From page 160...
... . Experimental animal studies found that the binding of arsenic is mainly to highmolecular-weight proteins in various tissues; however, arsenic is continuously released from most intracellular binding sites over time following exposure (Marafante et al.
From page 161...
... used neutron-activation analysis to assess the arsenic content of benign and malignant skin lesions of 14 patients exposed at least 4 years earlier to several years of inorganic arsenical medication. Arsenic content of the biopsied skin ranged from 0.8 to 8.9 ppm, and on average exceeded the arsenic content of normal skin and malignant skin lesions from six subjects with no history of
From page 162...
... In a study of pregnant women living in a village in northwestern Argentina where drinking water contains arsenic at about 200 µg/L, arsenic concentrations were about as high in cord blood (on average 9 µg/L) as in maternal blood, indicating that arsenic readily reaches the human fetus (Concha et al.
From page 163...
... . The arsenic concentrations found in human breast milk were slightly higher than the lowest concentrations reported in previous studies (Byrne et al.
From page 164...
... Kinetic Model A physiologically based pharmacokinetic (PB-PK) model for exposure to inorganic arsenic (orally, intravenously, and intratracheally)
From page 165...
... The extended model was validated against empirical data on the urinary excretion of the different metabolites of inorganic arsenic following repeated oral intake of arsenite, intake of inorganic arsenic via drinking water, and occupational exposure to arsenic trioxide. Predicted variation in urinary excretion of arsenic metabolites in relationship to form of arsenic absorbed, route of absorption, and time of urine sampling needs to be validated further.
From page 166...
... Experimental animal studies show that both inorganic arsenic and the methylated metabolites pass the placenta. In humans exposed to arsenic via drinking water, arsenic concentration in cord blood was similar to that in
From page 167...
... The excretion of arsenic in human milk is low, and in areas with high arsenic concentrations in the water, an infant is less exposed to arsenic via breast feeding than via formula prepared from the water. Recommendations Because of interspecies differences in the amounts of various arsenic species excreted in the urine and the amounts of methyltransferases in tissues, extrapolation of animal data to humans is generally not possible.
From page 168...
... 1981 a. Comparison of the urinary excretion of arsenic metabolites after a single dose of sodium arsenite, monomethylarsonate or dimethylarsinate in man.
From page 169...
... Part 2. Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy)
From page 170...
... 1987. Distribution, metabolism and fetal uptake of pentavalent arsenic in pregnant mice following oral or intraperitoneal administration.
From page 171...
... 1994. Dose-dependent disposition of sodium arsenite in mice following acute oral exposure.
From page 172...
... 1997. Some results of a physiologically based pharmacokinetic modeling approach to estimating arsenic body burdens.
From page 173...
... 1997. Factors influencing in vitro methylation of arsenicals in rat liver cytosol.
From page 174...
... 1997. Effect of hepatic methyl donor status on urinary excretion and DNA damage in B6C3F1 mice treated with sodium arsenite.
From page 175...
... Enzymatic methylation of arsenic compounds: III. The marmoset and tamarin, but not the rhesus, monkeys are deficient in methyltransferases that methylate inorganic arsenic.
From page 176...
... Page 176 Chemical speciation of arsenic in serum of uraemic patients. Analyst 123:13-17.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.